Falcon Therapeutics, Inc.
Chapel Hill, NC · Founded 2015 · CIK 0001709056 · Biotech · Defunct
Autologous induced neural stem cell (iNSC) carriers engineered from patient skin fibroblasts via SOX2-driven transdifferentiation, modified to deliver chemotoxic agents to glioblastoma tumors
- Grants
- $2.5M
- 3 awards
- Sector median: 1
- Raised
- $700K
- 1 Form D · Jun 2017
- 111 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Personalized Neural Stem Cell Therapy for Cancer | $225,000 | |
| Private capital raised | Form D · SEC | $700,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Personalized Neural Stem Cell Therapy for Cancer | $1,493,077 | |
| Federal grant | Department of Health and Human Services · Phase II · Personalized Neural Stem Cell Therapy for Cancer | $776,434 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2152 | KANNALIFE SCIENCES, INC. | — | $1.5M |
| 2153 | QRKANSWER LLC | — | — |
| 2154 | Valeo Pharma Inc. | — | $787K |
| 2155 | Falcon Therapeutics, Inc. | — | $700K |
| 2156 | Mindset Pharma Inc. | — | $694K |
| 2157 | Bitterroot Bio | — | — |
| 2158 | ASL Analytical, Inc. | — | $2.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Matthew EwendDirector
- Karen GirouxDirector · Executive Officer
- Shawn HingtgenDirector
- Anna SealDirector · Executive Officer
Patents
- Itdc Compositions And Methods For Use In Therapeutic Methodsapplication
- Engineered Stem Cell Constructs And Uses Thereofapplication
- Transdifferentiated Cell Compositions And Methods For Use In Therapeutic Methodsapplication
- Engineered Stem Cell Constructs And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.